Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Saparov, A.
Right arrow Articles by Weaver, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saparov, A.
Right arrow Articles by Weaver, C. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 11, No. 8, 1253-1264, August 1999
© 1999 Japanese Society for Immunology

Memory/effector T cells in TCR transgenic mice develop via recognition of enteric antigens by a second, endogenous TCR

Arman Saparov, Lisa A. Kraus, Yingzi Cong1, Jeff Marwill, Xiao-Yan Xu, Charles O. Elson1 and Casey T. Weaver

Departments of Pathology and
1 Medicine, University of Alabama at Birmingham, University Station, Birmingham, AL 35294, USA

Correspondence to: C. T. Weaver

The majority of clonotypic CD4+ T cells in the intestinal lamina propria of DO11.10 TCR transgenic mice have an activated/memory phenotype and produce effector cytokines despite the absence of prior exposure to ovalbumin (OVA), the transgene-specific antigen. A small number of splenic T cells have a similar phenotype. Clonotypic T cells from Peyer's patch are intermediate in both phenotype and effector cytokine production. Flow cytometric analysis of cells isolated from thymectomized, OVA-naive DO11.10 mice treated with continuous administration of BrdU indicated that a significant fraction of clonotype-positive T cells in the lamina propria and Peyer's patch were in the cell cycle, with significantly fewer cycling cells in the spleen. Most of the cycling cells from each anatomic site expressed low levels of CD45RB. Effector cytokine expression was enriched in the CD45RBlow populations. These memory/effector cell populations were eliminated in DO11.10/SCID and DO11.10/RAG-2–/– mice, suggesting that recognition of non-OVA antigens through a second, non-clonotypic TCR was driving differentiation of memory/effector cells in naive BALB/c DO11.10 mice. Clonotypic CD4+ T cells isolated from DO11.10, but not from DO11.10/SCID or DO11.10/RAG-2–/– mice, were stimulated to enter the cell cycle by antigen-presenting cells pulsed with an intestinal bacterial antigen extract. These data provide direct evidence that enteric bacterial antigens can activate transgenic T cells through a second, non-clonotypic TCR, and support the notion that the development and turnover of memory/effector cells in vivo is driven by the intestinal flora.

Keywords: CD4 T cell, cytokines, in situ hybridization, mucosal immunity, TCR transgenic mice, T cell memory

Transmitting editor: S. H. E. Kaufmann


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. J. McSorley, Y. M. Harcus, J. Murray, M. D. Taylor, and R. M. Maizels
Expansion of Foxp3+ Regulatory T Cells in Mice Infected with the Filarial Parasite Brugia malayi
J. Immunol., November 1, 2008; 181(9): 6456 - 6466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. L. Mora, J. LaVoy, M. McKean, A. Stecenko, K. L. Brigham, R. Parker, and M. Rojas
Prevention of NF-{kappa}B activation in vivo by a cell-permeable NF-{kappa}B inhibitor peptide
Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L536 - L544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. R. Sloma, M. J. Hansen, A. A. MacDougall, V. P. Van Keulen, R. B. Jenkins, and L. R. Pease
A Class I Transgene Reveals Regulatory Events on Chromosome 1 Marking Peripheral T Cell Differentiation and Memory
J. Immunol., June 15, 2005; 174(12): 7564 - 7572.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Turner, K. M. Dobos, M. A Keen, A. A. Frank, S. Ehlers, I. M. Orme, J. T. Belisle, and A. M. Cooper
A Limited Antigen-Specific Cellular Response Is Sufficient for the Early Control of Mycobacterium tuberculosis in the Lung but Is Insufficient for Long-Term Survival
Infect. Immun., July 1, 2004; 72(7): 3759 - 3768.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Zhou, R. Borojevic, C. Streutker, D. Snider, H. Liang, and K. Croitoru
Expression of Dual TCR on DO11.10 T Cells Allows for Ovalbumin-Induced Oral Tolerance to Prevent T Cell-Mediated Colitis Directed against Unrelated Enteric Bacterial Antigens
J. Immunol., February 1, 2004; 172(3): 1515 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E. Kondo, H. Wakao, H. Koseki, T. Takemori, S. Kojo, M. Harada, M. Takahashi, S. Sakata, C. Shimizu, T. Ito, et al.
Expression of recombination-activating gene in mature peripheral T cells in Peyer's patch
Int. Immunol., March 1, 2003; 15(3): 393 - 402.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Wei, T. Huang, H. Dalwadi, C. L. Sutton, D. Bruckner, and J. Braun
Pseudomonas fluorescens Encodes the Crohn's Disease-Associated I2 Sequence and T-Cell Superantigen
Infect. Immun., December 1, 2002; 70(12): 6567 - 6575.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Cong, C. T. Weaver, A. Lazenby, and C. O. Elson
Bacterial-Reactive T Regulatory Cells Inhibit Pathogenic Immune Responses to the Enteric Flora
J. Immunol., December 1, 2002; 169(11): 6112 - 6119.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. Iqbal, J. R. Oliver, F. H. Wagner, A. S. Lazenby, C. O. Elson, and C. T. Weaver
T Helper 1 and T Helper 2 Cells Are Pathogenic in an Antigen-specific Model of Colitis
J. Exp. Med., January 7, 2002; 195(1): 71 - 84.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. B. Reome, D. S. Johnston, B. K. Helmich, T. M. Morgan, N. Dutton-Swain, and R. W. Dutton
The Effects of Prolonged Administration of 5-Bromodeoxyuridine on Cells of the Immune System
J. Immunol., October 15, 2000; 165(8): 4226 - 4230.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.